The perioperative risks and factors associated with adverse cardiac outcomes in patients with dilated cardiomyopathy undergoing non-cardiac surgery are unknown. Interrogation of the Nelson Hospital transthoracic echocardiogram database identified 127 patients with dilated cardiomyopathy who satisfied the study criteria and underwent non-cardiac surgery between June 1999 and July 2013. Demographic and clinical data along with postoperative death within 30 days or a major adverse cardiac event were retrieved and analysed. The mean age was 75.9 years. Seventy-one percent of the patients had severe impairment of left ventricular function and 35% had a severely dilated left ventricle. A major adverse cardiac event occurred in 18.1% of patients and 5.5% of patients died within 30 days of surgery. Increased surgical risk and absence of cerebrovascular disease were associated with adverse outcome (P <0.001, P <0.05, respectively). Forty-three and a half percent (43.5%) of patients undergoing high-risk surgery had an adverse outcome compared to 36.1% and 5.9% for moderate and low-risk surgery, respectively. A major adverse cardiac event was observed in 26.7% of patients with cardiovascular disease compared to 9.8% of patients without cardiovascular disease. We were unable to exclude an influence of other potential risk factors due to the retrospective observational nature of the study. These findings highlight a potential increase in complications with moderate or high surgical risk, whilst are reassuring in demonstrating the relative safety of low-risk surgery in this group of high-risk patients.
Dilated cardiomyopathy (DCM) is a disease of the heart muscle characterised by progressive cardiac dilatation and a resultant global decrease in myocardial contractility and impaired systolic function of one or both ventricles. Cardiac ischaemia, valvular dysfunction and post-viral infection are among the identified causes of DCM. It has a prevalence of 36 per 100,000, predominantly affecting males. Malignant ventricular arrhythmias are the most common cause of death in DCM. Advances in the care of cardiac patients have led to an increased life expectancy in this group and with the ever increasing demand for surgery, particularly in the elderly, it is likely that patients with DCM will present more frequently to the anaesthetist.
This patient group is under-represented in the literature and studies are limited mainly to case reports of anaesthetic management, thus little evidence exists around potential predictors of morbidity and mortality [1] [2] [3] [4] [5] [6] [7] [8] . Establishing a more defined perioperative risk profile would facilitate better surgical and anaesthetic informed consent, and more appropriate planning for higher risk cases. For this reason, we undertook this respective observational study of our institution's experience in relation to patients with DCM undergoing non-cardiac surgery.
Methods
The study was a retrospective single-centre observational review of patients with DCM undergoing non-cardiac surgical procedures. The New Zealand Ethics Committee indicated that the study was outside its scope for requiring ethics approval or informed consent (HDEC ref: 17/NTB/75) as it involved case note review only, no interventions were being assessed and patient confidentiality and privacy would not be affected. Patients were identified through preoperative echocardiograms by interrogating the Nelson Hospital transthoracic echocardiography (TTE) database of records compiled between June 1999 and July 2013 where the request indication was "preoperative echocardiogram". The database identified 127 patients undergoing noncardiac surgery who met the inclusion criteria of having a left ventricular ejection fraction (LVEF) ≤40% and a dilated left ventricle as determined by an increased left ventricular diastolic internal diameter (LVIDd). TTE variables were categorised according to the American Society of Echocardiography's values for normal range and severity 9 . An LVEF of 30% to 40% was classified as moderately impaired. If the LVEF was <30%, it was classified as severely impaired. An LVIDd measurement of 5.4 to 6.1 cm in women and 6.0 to 6.8 cm in men was classified as mild/moderately dilated and values of ≥6.2 cm in women and ≥6.9 cm in men were classified as severely dilated.
The following variables were collected from the patients' clinical records: gender, age, surgical risk, type of anaesthetic, 10 . Laboratory values of preoperative haemoglobin and serum creatinine concentrations were also recorded.
The patient's ASA physical status was determined by the anaesthetising clinician. Lee's RCRI consists of six components, namely high-risk surgical procedure, IHD, heart failure, CVD, IDDM and CRF, each scoring one point. Surgical risk was defined as high risk for the following operations; aortic and major vascular surgery, peripheral vascular surgery, anticipated prolonged procedures associated with large fluid shifts or blood loss, and emergency surgery in the elderly. Moderate-risk surgery included carotid endarterectomy, head and neck surgery, intraperitoneal and intrathoracic surgery, orthopaedic surgery and prostate surgery. Low-risk surgery consisted of endoscopic procedures, superficial surgery, cataract surgery and breast surgery. IHD was defined as a history of myocardial infarction, angina, use of sublingual nitroglycerine, a positive exercise tolerance test, Q waves on electrocardiography (ECG) and patients who had undergone percutaneous coronary angioplasty or coronary artery bypass grafting and who have chest pain presumed to be of ischaemic origin. Heart failure was defined as history of paroxysmal nocturnal dyspnoea or pulmonary oedema, signs of left ventricular failure on physical examination, added third heart sound or bilateral rales on auscultation of the chest, or pulmonary oedema on chest X-ray. CVD was defined as a history of a transient ischaemic attack or cerebrovascular accident. Chronic renal insufficiency was defined as a baseline creatinine of 170 µmol/l or greater.
The endpoint of the study was an in-hospital major adverse cardiac event (MACE) with acute haemodynamic instability (defined as major cardiac arrhythmia, acute heart failure, acute myocardial infarction or cardiac arrest) and/or death within 30 days. The associations between preoperative factors and the primary outcome were tested using Pearson's chi-square test for non-parametric data and analysis of variance (ANOVA) for continuous variables (SPSS, IBM Corp, NY, USA). Serum creatinine is presented as median and interquartile range and was analysed using the Mann-Whitney U-test as it did not follow a normal distribution. A P-value <0.05 was taken to indicate statistical significance. 
Results
In total, 127 patients were included in the study, of whom 28 were female (22%) and 99 were male (78%), ranging from age 56 to 93 years with a mean age of 75.9±8.7 years (mean ± standard deviation [SD]). Of these, 96 patients (75.9%) had IHD, 52 (40.9%) had CHF, 41 (32.3%) had CVD and 24 (27%) had an RCRI of three or greater. Sixty-one and a half percent (61.5%) were classified as ASA physical status 3 and 33.1% were classified as ASA physical status 4. One patient did not have an ASA physical status classification recorded in the notes and one was graded as ASA physical status 2 by the assessing clinician, which is not likely representative of a patient with DCM and an ejection fraction ≤40%.
The majority of surgical procedures undertaken were lowrisk (51.0%), with 31.3% undergoing moderate-risk surgery and 17.7% high-risk surgery. General anaesthesia was more frequent than non-general anaesthetic techniques, with 91 patients (71.7%) in the former group and 36 patients (28.3%) in the latter. Seventy-one percent (71%) of patients had severe impairment of LVEF, and 34.6 % had a severely dilated left ventricle. The mean LVEF and LVIDd were 26.9%±7.8% and 6.5±0.8 cm (mean ± SD) respectively. The primary outcome occurred in 27 (21%) patients, of whom 20 (16%) had a MACE and seven died (5.5%) within 30 days of surgery.
ANOVA testing of the continuous variables found no statistically significant associations with postoperative MACE and/or death within 30 days of surgery. Similarly, there was no statistically significant association between serum creatinine and the primary outcome ( Table 1) .
The univariate analysis of the categorical variables is shown in Table 2 with the individual components of the RCRI (except surgical risk) shown in Table 3 . No patient scored an RCRI of six.
The only significant associations with the primary outcome were surgical risk (P <0.001) and absence of CVD (P <0.05). Patients undergoing high-and moderate-risk surgery were more likely to have a MACE than patients undergoing lowrisk procedures. Of the 23 patients who underwent high-risk surgery, 10 (43.5%) suffered the primary outcome as did 13 (36.1%) of the 36 undergoing moderate-risk surgery, compared to four (5.9%) in the low-risk group. One patient undergoing low-risk surgery died within 30 days of surgery compared to three patients undergoing moderate-risk surgery and three undergoing high-risk surgery. Patients with known CVD had lower rates of a MACE than those without ( χ 2 =4.786, P <0.05). A MACE was observed in 23 of the 86 (26.7%) patients without CVD compared with only four of the 41 (9.8%) patients with CVD. There were no other statistically significant predictors of a MACE in other univariate analyses.
Discussion
We found that 21% of patients with DCM in our retrospective observational study had a composite outcome of a MACE or death within 30 days of non-cardiac surgery, and 5.5% died. These findings apply to the range and proportion of procedures undertaken in our institution, and the severity of the DCM in the included patients. It is not possible to extrapolate these findings to other institutions without considering these patient and surgical factors. There are no similar studies of DCM to compare these outcomes. Moreover, the lack of a control group limits our ability to determine whether DCM is associated with worse outcomes than a cohort of patients with similar comorbidities but no DCM.
Unfortunately, it was not possible using our hospital's clinical records to define a suitable control group. A review of the literature looking at similar groups of elderly patients with multiple comorbidities provides some comparative values to reference against our results. A recent study looking at age and surgical mortality in over 3,000,000 patients in Poland found a 2% overall in-hospital mortality if over 65 years of age 11 . This doubled for each decade over 65 years, with mortality exceeding 10% in those over 85 years. Based on these figures, with a mean age of 76 years, our expected mortality would be around 4%, which is slightly lower than the reported 5.5%. The REASON study recorded morbidity and mortality in patients aged over 70 years undergoing non-cardiac surgery 12 . Of the 4,158 patients included in the study, two-thirds were ASA physical status 3 or greater, 20% of patients had a complication within five days and 5% died within 30 days. The values given in our study are similar to those reported, but the complications in the REASON study include all complications rather than just MACE. The combined frequency of acute pulmonary oedema, acute myocardial infarction and cardiac arrest in the REASON study was 6%, which is much lower than that found in our cohort of patients. It may not seem surprising that the occurrence of MACE is higher in patients with DCM, but mortality rates overall seem similar to previous reports of patients who do not have DCM. This result may seem at odds with the perceived increased risk, but the rates cannot be compared directly, and should be interpreted with caution. Nevertheless, it is possible that the perioperative high acuity care of our patients with known DCM influenced the mortality rates. Studies investigating patients with cardiac disease often focus on coronary artery disease (CAD) and CHF. The POISE study recruited patients with, or at risk of, atherosclerotic disease 13 . The study had a composite endpoint of CVD, non-fatal myocardial infarction and non-fatal cardiac arrest. The endpoint was reached in 5.8% of the group taking betablockers and 6.9% in the control group. In two studies looking at patients undergoing surgery post-cardiac stents, a MACE frequency of 3% to 4% was reported, which increased to 8.3% if the RCRI was ≥3 and 12% if the patient had a history of CHF 14, 15 . The increased risk with CHF has been identified in other studies and shown to have a risk greater than CAD. Hernandez et al looked at 30-day mortality in patients with a history of CHF compared to those with CAD and a control group. Twelve percent (12%) of the CHF patients died compared to 6% in the CAD and control groups 17 . Other studies have reported similar frequencies with unadjusted crude 30-day mortality rates in patients with a history of heart failure of 8% to 9% [18] [19] [20] . Healy et al stratified their patients according to LVEF 20 . Overall, the incidence of MACE and death within 30 days was 30%, with a mortality of 8% that increased to 14% if the LVEF was ≤30%. The frequencies of MACE in our study align more with values seen in patients with a history of CHF than those with CAD. This may not seem surprising if one assumes all patients with DCM have a history of CHF. However, in our cohort, 75% of patients had CAD and 40% a history of CHF, yet the primary outcome occurred approximately equally in both groups with neither factor predictive of the outcome.
Variables significantly associated with the study outcome were higher risk surgery and no history of CVD. However, an influence of other risk factors cannot be excluded due to the retrospective observational nature of the study and the relatively small sample size. The relevance of the CVD finding is uncertain, but may reflect the subsequent management of risk factors with blood pressure control, statins and aspirin in these patients. It is also possible that a history of previous CVD in addition to DCM changed perioperative management with beneficial effects on outcome. It is also worth noting that in the absence of a control group, it cannot be determined whether surgical risk and outcome are related, independent of DCM. None of the preoperative TTE measures appeared to influence surgical approach or anaesthetic technique, but we did not examine this directly. It is possible that a more detailed examination of cardiac physiology, such as cardiopulmonary exercise testing or a different TTE measurement such as stroke volume, may be more predictive of MACE or death, particularly in patients undergoing higher risk surgical procedures.
Limitations
Limitations of the study include the single-centre, retrospective, observational nature of the study and a small sample size. The sample size was limited by the numbers of patients available on the database. Moreover, confirmation of potential risk factors would require a prospective approach with sufficient power to identify or exclude clinically important effects. Additionally, the small sample size may explain some of the anomalies seen, such as the higher rate of MACE in patients with moderate compared to severe DCM. Inherent to the subjective nature of the ASA physical status classification system, some patients in this study may have been inappropriately classified by assessing clinicians with regard to their ASA status. These limitations are important and the results should be interpreted with a degree of caution.
The results also have the potential to be influenced by the type of surgical procedures performed at Nelson Hospital and by changes in anaesthetic and surgical practice over time. The study did not examine operative and postoperative variables that could have an effect on outcome (e.g. surgical expertise, duration of surgery, blood loss, haemodynamic rate control, postoperative care). Which of these variables to collect was hard to determine and ultimately a pragmatic approach was needed to limit the number of variables and to align the study with the preoperative assessment process where intraoperative and postoperative variables are often unknown.
Despite these limitations the study provides perioperative outcome data in patients with DCM undergoing non-cardiac surgery beyond case reports. These data could potentially be used when designing a pilot study for future prospective research. The study highlights a potential increase in complications with moderate or high surgical risk, whilst it is also reassuring in demonstrating the relative safety of lowrisk surgery. These findings would need to be confirmed and tested prospectively.
